Loading...
STRATA Skin Sciences, Inc.
SSKN•NASDAQ
Healthcare
Medical - Devices
$1.96
$-0.06(-2.97%)
STRATA Skin Sciences, Inc. (SSKN) Financial Performance & Income Statement Overview
Review STRATA Skin Sciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.61%
↑ 0.61%
Operating Income Growth
-7.57%
↓ 7.57%
Net Income Growth
6.87%
↑ 6.87%
Operating Cash Flow Growth
136.22%
↑ 136.22%
Operating Margin
-24.93%
↓ 24.93%
Gross Margin
58.44%
↑ 58.44%
Net Profit Margin
-27.22%
↓ 27.22%
ROE
-138.22%
↓ 138.22%
ROIC
-43.83%
↓ 43.83%
STRATA Skin Sciences, Inc. (SSKN) Income Statement & Financial Overview
Review STRATA Skin Sciences, Inc.'s (SSKN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $9.58M | $8.80M | $8.44M | $6.75M |
| Cost of Revenue | $3.82M | $3.49M | $3.50M | $3.67M |
| Gross Profit | $5.76M | $5.31M | $4.94M | $3.08M |
| Gross Profit Ratio | $0.60 | $0.60 | $0.59 | $0.46 |
| R&D Expenses | $200000.00 | $243000.00 | $199000.00 | $241000.00 |
| SG&A Expenses | $5.92M | $6.72M | $5.22M | $5.73M |
| Operating Expenses | $9.98M | $6.96M | $5.42M | $5.97M |
| Total Costs & Expenses | $13.80M | $10.45M | $8.92M | $9.64M |
| Interest Income | $75000.00 | $68000.00 | $54000.00 | $45000.00 |
| Interest Expense | $515000.00 | $537000.00 | $531000.00 | $524000.00 |
| Depreciation & Amortization | $1.31M | $1.32M | $1.33M | $1.34M |
| EBITDA | -$2.84M | -$265000.00 | $1.76M | -$1.50M |
| EBITDA Ratio | -$0.30 | -$0.03 | $0.21 | -$0.22 |
| Operating Income | -$4.23M | -$1.65M | -$486000.00 | -$2.89M |
| Operating Income Ratio | -$0.44 | -$0.19 | -$0.06 | -$0.43 |
| Other Income/Expenses (Net) | -$440000.00 | -$469000.00 | $387000.00 | -$492000.00 |
| Income Before Tax | -$4.67M | -$2.12M | -$99000.00 | -$3.37M |
| Income Before Tax Ratio | -$0.49 | -$0.24 | -$0.01 | -$0.50 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$4.50M | -$2.12M | -$99000.00 | -$3.37M |
| Net Income Ratio | -$0.47 | -$0.24 | -$0.01 | -$0.50 |
| EPS | -$1.18 | -$0.53 | -$0.03 | -$1.00 |
| Diluted EPS | -$1.18 | -$0.53 | -$0.03 | -$1.00 |
| Weighted Avg Shares Outstanding | $3.81M | $4.04M | $3.51M | $3.51M |
| Weighted Avg Shares Outstanding (Diluted) | $3.81M | $4.04M | $3.51M | $3.51M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan